The Women's Circle of Health Follow-Up Study: a population-based longitudinal study of Black breast cancer survivors in New Jersey.


Journal

Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557

Informations de publication

Date de publication:
06 2020
Historique:
received: 24 08 2019
accepted: 17 12 2019
pubmed: 8 1 2020
medline: 18 11 2020
entrez: 8 1 2020
Statut: ppublish

Résumé

The Women's Circle of Health Follow-Up Study is an ongoing longitudinal study of African American/Black breast cancer survivors in New Jersey, specifically designed to evaluate the impact of obesity and related comorbidities on breast cancer survival and health-related quality-of-life in this understudied population. Here, we describe our recruitment and data collection methods and compare characteristics of the overall cohort and the subcohort with follow-up data. Newly diagnosed breast cancer cases have been recruited into the study since 2006. Pre-diagnosis data on relevant factors and a saliva sample are collected during an in-person interview within 12 months from diagnosis. In 2013, we began active follow up by recontacting participants annually, including two home visits at approximately 2 and 3 years post-diagnosis, during which blood samples are collected. Mortality outcomes (all-cause and breast cancer-specific mortality) are ascertained through linkage with New Jersey State Cancer Registry files. We expect to assemble a cohort of over 2000 Black breast cancer survivors with at least 800 of them having detailed post-diagnosis data. Distribution of sociodemographic characteristics, body mass index, comorbidities, clinicopathologic characteristics, and treatment modalities were very similar between those in the full cohort and the subset with follow-up data and blood samples. Obesity (> 50%), hypertension (> 58%), and diabetes (22%) were common in this population. This ongoing longitudinal study represents a unique resource to better understand breast cancer outcomes, patient-reported symptoms, and health-related quality of life among Black breast cancer survivors.

Identifiants

pubmed: 31907766
doi: 10.1007/s11764-019-00849-8
pii: 10.1007/s11764-019-00849-8
pmc: PMC7261243
mid: NIHMS1548299
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-346

Subventions

Organisme : NCI NIH HHS
ID : K01 CA193527
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016056
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA072720
Pays : United States
Organisme : NIMHD NIH HHS
ID : R00 MD013300
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA151135
Pays : United States
Organisme : NIMHD NIH HHS
ID : K99 MD013300
Pays : United States
Organisme : NCI NIH HHS
ID : K07 CA222158
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201300021C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201200021I
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA185623
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA100598
Pays : United States

Références

JAMA. 2005 Oct 12;294(14):1765-72
pubmed: 16219879
J Relig Health. 2011 Dec;50(4):1040-53
pubmed: 20953712
Adv Exp Med Biol. 2015;862:155-75
pubmed: 26059935
J Cancer Surviv. 2013 Jun;7(2):253-61
pubmed: 23417882
J Health Psychol. 2010 May;15(4):615-26
pubmed: 20460418
JAMA. 2014 Jul;312(2):189-90
pubmed: 25005661
Neurosci Lett. 2004 May 6;361(1-3):184-7
pubmed: 15135924
J Oncol. 2009;2009:871250
pubmed: 19865486
Int J Cancer. 2015 Aug 1;137(3):666-77
pubmed: 25598430
Nutr Cancer. 2014;66(7):1187-99
pubmed: 25265504
Ethn Dis. 2006 Autumn;16(4):943-7
pubmed: 17061751
Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1575-7
pubmed: 16985014
Curr Drug Saf. 2013 Nov;8(5):357-63
pubmed: 24215316
JAMA. 1992 Mar 25;267(12):1617-23
pubmed: 1542171
Am J Ind Med. 1996 Jun;29(6):602-8
pubmed: 8773720
Adv Nutr. 2015 Nov 13;6(6):803-19
pubmed: 26567202
J Natl Black Nurses Assoc. 2006 Jul;17(1):45-50
pubmed: 17004426
J Clin Oncol. 2012 Oct 20;30(30):3726-33
pubmed: 23008299
Int J Cancer. 2014 Mar 15;134(6):1408-21
pubmed: 23996684
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Clin Diabetes. 2015 Apr;33(2):97-111
pubmed: 25897193
Cancer Causes Control. 2019 Apr;30(4):395-408
pubmed: 30835011
J Rheumatol. 2005 May;32(5):811-9
pubmed: 15868614
Ann Behav Med. 2002 Winter;24(1):49-58
pubmed: 12008794
Ann Surg Oncol. 2015 Apr;22(4):1095-101
pubmed: 25245129
J Cancer Surviv. 2018 Aug;12(4):460-468
pubmed: 29536415
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
PLoS One. 2013 Aug 21;8(8):e72619
pubmed: 23991131
Brain Behav Immun. 2002 Oct;16(5):503-12
pubmed: 12401464
BMC Cancer. 2013 Oct 14;13:475
pubmed: 24118876
Breast Cancer Res Treat. 2013 Oct;141(3):447-59
pubmed: 24062209
Obesity (Silver Spring). 2009 Jan;17(1):169-76
pubmed: 19107129
Psychosom Med. 2003 Jul-Aug;65(4):571-81
pubmed: 12883107
Breast Cancer Res Treat. 2012 Nov;136(2):323-30
pubmed: 22918525
Int J Cancer. 2009 Mar 1;124(5):1213-9
pubmed: 19058216
J Womens Health (Larchmt). 2015 Mar;24(3):209-17
pubmed: 25650628
Cancer Causes Control. 2008 Dec;19(10):1065-76
pubmed: 18478338
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
PLoS One. 2012;7(7):e40560
pubmed: 22844404
J Clin Oncol. 1997 Mar;15(3):974-86
pubmed: 9060536
Clin Breast Cancer. 2015 Dec;15(6):426-31
pubmed: 26516037
Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1115-20
pubmed: 24718280
Cancer Causes Control. 2013 Dec;24(12):2217-29
pubmed: 24091794
Int J Cancer. 2014 Mar 15;134(6):1422-35
pubmed: 23996837
Breast Cancer Res. 2012 Apr 04;14(2):R58
pubmed: 22480149
Circulation. 2005 Feb 8;111(5):697-716
pubmed: 15699287
Health Econ. 1993 Oct;2(3):217-27
pubmed: 8275167
Int J Behav Med. 2008;15(3):194-200
pubmed: 18696313
J Clin Epidemiol. 1999 Feb;52(2):105-11
pubmed: 10201650
Annu Rev Nutr. 2012 Aug 21;32:311-42
pubmed: 22540252
Am J Epidemiol. 1986 Sep;124(3):453-69
pubmed: 3740045
Carcinogenesis. 2017 Sep 1;38(9):883-892
pubmed: 28605409
ABNF J. 2006 Spring;17(2):89-94
pubmed: 18402350
JAMA. 2014 Sep 17;312(11):1151-3
pubmed: 25226482
Biol Res Nurs. 2013 Apr;15(2):226-33
pubmed: 22084401
Cancer Causes Control. 2005 Jun;16(5):545-56
pubmed: 15986109
Cancer Causes Control. 2015 Dec;26(12):1737-50
pubmed: 26376894
CA Cancer J Clin. 2019 May;69(3):211-233
pubmed: 30762872
Cancer Causes Control. 2013 Apr;24(4):675-84
pubmed: 23329367
Breast Cancer Res Treat. 2006 Jun;97(3):245-54
pubmed: 16331345
Clin Cancer Res. 2006 May 1;12(9):2759-66
pubmed: 16675568
Breast Cancer (Dove Med Press). 2017 Dec 01;9:559-565
pubmed: 29238220
Cancer Causes Control. 2014 Feb;25(2):259-65
pubmed: 24249438
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28376154
Brain Behav Immun. 2007 May;21(4):413-27
pubmed: 17178209
Ann Surg Oncol. 2014 Oct;21(11):3473-80
pubmed: 24912611
Cytokine. 2012 Jun;58(3):437-47
pubmed: 22450224
Ann Rheum Dis. 2004 Apr;63(4):335-41
pubmed: 15020324
Soc Sci Med. 2005 Oct;61(7):1576-96
pubmed: 16005789
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
Cancer Nurs. 2012 Sep-Oct;35(5):355-64
pubmed: 22495496
Br J Cancer. 2013 Oct 1;109(7):1945-53
pubmed: 24008665
Am J Epidemiol. 2009 Feb 15;169(4):428-34
pubmed: 19056835
Cancer Causes Control. 2013 Dec;24(12):2231-43
pubmed: 24113797
Ethn Dis. 2004 Autumn;14(4):463-8
pubmed: 15724763
J Clin Oncol. 2004 Sep 1;22(17):3570-80
pubmed: 15337807
Curr Oncol Rep. 2019 Mar 27;21(5):41
pubmed: 30919143
Womens Health (Lond). 2011 Nov;7(6):677-87
pubmed: 22040209
J Clin Hypertens (Greenwich). 2005 Feb;7(2):102-9
pubmed: 15722655
Ann Oncol. 2014 Oct;25(10):1901-14
pubmed: 24769692

Auteurs

Elisa V Bandera (EV)

Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ, 08903, USA. elisa.bandera@rutgers.edu.
Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA. elisa.bandera@rutgers.edu.

Kitaw Demissie (K)

Department of Epidemiology and Biostatistics, School of Public Health, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.

Bo Qin (B)

Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ, 08903, USA.

Adana A M Llanos (AAM)

Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ, 08903, USA.
Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA.

Yong Lin (Y)

Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ, 08903, USA.
Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA.

Baichen Xu (B)

Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ, 08903, USA.

Karen Pawlish (K)

Cancer Epidemiology Services, New Jersey State Cancer Registry, Trenton, NJ, USA.

Jesse J Plascak (JJ)

Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ, 08903, USA.
Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA.

Jennifer Tsui (J)

Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ, 08903, USA.
Department of Health Behavior, Society & Policy, Rutgers School of Public Health, Piscataway, NJ, USA.

Angela R Omilian (AR)

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

William McCann (W)

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Song Yao (S)

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Christine B Ambrosone (CB)

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Chi-Chen Hong (CC)

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH